Post-mortem lung tissue: the fossil record of the pathophysiology and immunopathology of severe COVID-19

Lancet Respir Med. 2022 Jan;10(1):95-106. doi: 10.1016/S2213-2600(21)00408-2. Epub 2021 Dec 3.

Abstract

The lungs are the main site that is affected in severe COVID-19, and post-mortem lung tissue provides crucial insights into the pathophysiology of severe disease. From basic histology to state-of-the-art multiparameter digital pathology technologies, post-mortem lung tissue provides snapshots of tissue architecture, and resident and inflammatory cell phenotypes and composition at the time of death. Contrary to early assumptions that COVID-19 in the lungs is a uniform disease, post-mortem findings have established a high degree of disease heterogeneity. Classic diffuse alveolar damage represents just one phenotype, with disease divisible by early and late progression as well as by pathophysiological process. A distinct lung tissue state occurs with secondary infection; extrapulmonary causes of death might also originate from a pathological process in the lungs linked to microthrombosis. This heterogeneity of COVID-19 lung disease must be recognised in the management of patients and in the development of novel treatment strategies.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Autopsy
  • COVID-19* / immunology
  • COVID-19* / pathology
  • Fossils
  • Humans
  • Lung* / pathology
  • Lung* / physiopathology
  • Lung* / virology
  • Patient Acuity
  • SARS-CoV-2